422 related articles for article (PubMed ID: 17096434)
21. EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer.
Smouse JH; Cibas ES; Jänne PA; Joshi VA; Zou KH; Lindeman NI
Cancer; 2009 Feb; 117(1):67-72. PubMed ID: 19347832
[TBL] [Abstract][Full Text] [Related]
22. Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients.
Murray S; Timotheadou E; Linardou H; Vrettou AV; Kostopoulos I; Skrickova J; Papakostantinou C; Christodoulou C; Pectasides D; Samantas E; Papakostas P; Skarlos DV; Kosmidis P; Fountzilas G
Lung Cancer; 2006 May; 52(2):225-33. PubMed ID: 16567021
[TBL] [Abstract][Full Text] [Related]
23. Colorimetric detection of mutations in epidermal growth factor receptor using gold nanoparticle aggregation.
Lee H; Kang T; Yoon KA; Lee SY; Joo SW; Lee K
Biosens Bioelectron; 2010 Mar; 25(7):1669-74. PubMed ID: 20036793
[TBL] [Abstract][Full Text] [Related]
24. Tumour necrosis factor receptor superfamily member 6 gene mutation detection by denaturing high-performance liquid chromatography.
Etokebe GE; Abrahamsen TG; Bogen B; Spurkland A
Scand J Immunol; 2004 May; 59(5):496-503. PubMed ID: 15140060
[TBL] [Abstract][Full Text] [Related]
25. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening.
Jänne PA; Borras AM; Kuang Y; Rogers AM; Joshi VA; Liyanage H; Lindeman N; Lee JC; Halmos B; Maher EA; Distel RJ; Meyerson M; Johnson BE
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):751-8. PubMed ID: 16467085
[TBL] [Abstract][Full Text] [Related]
26. Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.
Kancha RK; von Bubnoff N; Peschel C; Duyster J
Clin Cancer Res; 2009 Jan; 15(2):460-7. PubMed ID: 19147750
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.
Blons H; Côté JF; Le Corre D; Riquet M; Fabre-Guilevin E; Laurent-Puig P; Danel C
Am J Surg Pathol; 2006 Oct; 30(10):1309-15. PubMed ID: 17001163
[TBL] [Abstract][Full Text] [Related]
28. Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.
Nagahara H; Mimori K; Ohta M; Utsunomiya T; Inoue H; Barnard GF; Ohira M; Hirakawa K; Mori M
Clin Cancer Res; 2005 Feb; 11(4):1368-71. PubMed ID: 15746034
[TBL] [Abstract][Full Text] [Related]
29. PCR-based testing for therapy-related EGFR mutations in patients with non-small cell lung cancer.
Dahse R; Berndt A; Kosmehl H
Anticancer Res; 2008; 28(4B):2265-70. PubMed ID: 18751405
[TBL] [Abstract][Full Text] [Related]
30. Comparison study of the performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer.
Cushman-Vokoun AM; Crowley AM; Rapp SA; Greiner TC
Am J Clin Pathol; 2013 Jul; 140(1):7-19. PubMed ID: 23765529
[TBL] [Abstract][Full Text] [Related]
31. Impact of EGFR mutation analysis in non-small cell lung cancer.
Yamamoto H; Toyooka S; Mitsudomi T
Lung Cancer; 2009 Mar; 63(3):315-21. PubMed ID: 18760859
[TBL] [Abstract][Full Text] [Related]
32. Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography.
Biggin A; Henke R; Bennetts B; Thorburn DR; Christodoulou J
Mol Genet Metab; 2005 Jan; 84(1):61-74. PubMed ID: 15639196
[TBL] [Abstract][Full Text] [Related]
33. Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma.
Brachtel EF; Iafrate AJ; Mark EJ; Deshpande V
Diagn Cytopathol; 2007 May; 35(5):257-62. PubMed ID: 17427221
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor mutation testing in the care of lung cancer patients.
Sequist LV; Joshi VA; Jänne PA; Bell DW; Fidias P; Lindeman NI; Louis DN; Lee JC; Mark EJ; Longtine J; Verlander P; Kucherlapati R; Meyerson M; Haber DA; Johnson BE; Lynch TJ
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4403s-4408s. PubMed ID: 16857818
[TBL] [Abstract][Full Text] [Related]
35. Searching for a magic bullet in NSCLC: the role of epidermal growth factor receptor mutations and tyrosine kinase inhibitors.
Wong KK
Lung Cancer; 2008 Jun; 60 Suppl 2():S10-8. PubMed ID: 18513579
[TBL] [Abstract][Full Text] [Related]
36. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
[TBL] [Abstract][Full Text] [Related]
37. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection.
O'Donovan MC; Oefner PJ; Roberts SC; Austin J; Hoogendoorn B; Guy C; Speight G; Upadhyaya M; Sommer SS; McGuffin P
Genomics; 1998 Aug; 52(1):44-9. PubMed ID: 9740670
[TBL] [Abstract][Full Text] [Related]
38. Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.
Andrulis IL; Anton-Culver H; Beck J; Bove B; Boyd J; Buys S; Godwin AK; Hopper JL; Li F; Neuhausen SL; Ozcelik H; Peel D; Santella RM; Southey MC; van Orsouw NJ; Venter DJ; Vijg J; Whittemore AS;
Hum Mutat; 2002 Jul; 20(1):65-73. PubMed ID: 12112659
[TBL] [Abstract][Full Text] [Related]
39. Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography.
Greiner TC
Diagn Mol Pathol; 2007 Mar; 16(1):32-7. PubMed ID: 17471156
[TBL] [Abstract][Full Text] [Related]
40. NF1 gene analysis based on DHPLC.
De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]